Dr Joan Cassettari, DO | |
253 Pleasant St, Concord, NH 03301-7560 | |
(603) 228-4548 | |
Not Available |
Full Name | Dr Joan Cassettari |
---|---|
Gender | Female |
Speciality | Allergy & Immunology |
Location | 253 Pleasant St, Concord, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952328999 | NPI | - | NPPES |
800000373 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 7605 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joan Cassettari, DO 253 Pleasant St, Concord, NH 03301-7560 Ph: (603) 228-4548 | Dr Joan Cassettari, DO 253 Pleasant St, Concord, NH 03301-7560 Ph: (603) 228-4548 |
News Archive
Schools are closing again in response to surging levels of COVID-19 infection, but staging randomised trials when students eventually return could help to clarify uncertainties around when we should send children back to the classroom, according to a new study.
A trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 percent of the time, according to a new study, to- be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
Cases of ventilator-associated pneumonia — the most lethal and among the most common of all hospital-associated infections — dropped by more than 70 percent in Michigan hospitals where medical staff used a simple checklist designed by Johns Hopkins researchers. Such pneumonias kill an estimated 36,000 Americans each year.
A new COVID-19 global surveillance system has been developed which can dynamically track not just where the virus is now, but where it is going, how fast it will arrive and whether that speed is accelerating.
Individuals with bipolar disorder have the lowest risk of rehospitalization if treated with lithium, according to a study from Karolinska Institutet in Sweden published in JAMA Psychiatry. Long-acting injections of antipsychotics were also effective, reducing the risk of rehospitalization by 30 percent compared with their oral counterparts.
› Verified 4 days ago